{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:27:24Z","timestamp":1753889244539},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Women's Health Issues"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.whi.2005.12.001","type":"journal-article","created":{"date-parts":[[2006,2,17]],"date-time":"2006-02-17T12:10:46Z","timestamp":1140178246000},"page":"14-21","source":"Crossref","is-referenced-by-count":6,"title":["Determinants of physician unwillingness to offer medical abortion using mifepristone"],"prefix":"10.1016","volume":"16","author":[{"given":"Michelle D.","family":"Seelig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lillian","family":"Gelberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Tavrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa V.","family":"Rubenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.whi.2005.12.001_bib1","first-page":"1","article-title":"Fertility, family planning, and women\u2019s health","volume":"23","author":"Abma","year":"1997","journal-title":"Vital Health Statistics"},{"key":"10.1016\/j.whi.2005.12.001_bib2","unstructured":"Alan Guttmacher Institute (AGI). (2005). Facts in brief: Induced abortion. Available: http:\/\/www.agi-usa.org\/pubs\/fb_induced_abortion.html. Accessed April 13, 2005."},{"key":"10.1016\/j.whi.2005.12.001_bib3","unstructured":"Alan Guttmacher Institute (AGI). (2004). Annual report planned parenthood. Available: http:\/\/www.lifeissues.org\/pp\/report-04.pdf. Accessed April 13 2005."},{"key":"10.1016\/j.whi.2005.12.001_bib4","unstructured":"Alan Guttmacher Institute (AGI). (2005). Facts in brief: Induced abortion in the United States. Accessed October 21, 2005."},{"key":"10.1016\/j.whi.2005.12.001_bib5","series-title":"Marketing social change","author":"Andreasen","year":"1995"},{"key":"10.1016\/j.whi.2005.12.001_bib6","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1093\/humrep\/13.10.2962","article-title":"An effective regimen for early medical abortion","volume":"13","author":"Ashok","year":"1998","journal-title":"Human Reproduction"},{"key":"10.1016\/j.whi.2005.12.001_bib7","first-page":"529","article-title":"Racial\/ethnic trends in fetal mortality\u2014United States, 1990\u20132000","volume":"53","author":"Barfield","year":"2004","journal-title":"Surveillance Summaries"},{"key":"10.1016\/j.whi.2005.12.001_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1049-3867(01)00141-4","article-title":"The delivery of medical abortion services","volume":"12","author":"Beckman","year":"2002","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.whi.2005.12.001_bib9","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1056\/NEJM200003303421307","article-title":"Medical termination of pregnancy","volume":"342","author":"Christin-Maitre","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"3 Suppl","key":"10.1016\/j.whi.2005.12.001_bib10","first-page":"177","article-title":"Is medical abortion acceptable to all American women","volume":"55","author":"Clark","year":"2000","journal-title":"Journal of the American Medical Women\u2019s Association"},{"issue":"12","key":"10.1016\/j.whi.2005.12.001_bib11","first-page":"1","article-title":"Abortion surveillance\u2014United States, 2000","volume":"52","author":"Elam-Evans","year":"2003","journal-title":"Surveillance Summaries"},{"key":"10.1016\/j.whi.2005.12.001_bib12","first-page":"91","article-title":"Providing mifepristone-misoprostol medical abortion","volume":"54","author":"Ellertson","year":"1999","journal-title":"Journal of the American Medical Women\u2019s Association"},{"issue":"3 Suppl","key":"10.1016\/j.whi.2005.12.001_bib13","first-page":"169","article-title":"In-depth interviews with medical abortion clients","volume":"55","author":"Elul","year":"2000","journal-title":"Journal of the American Medical Women\u2019s Association"},{"issue":"1","key":"10.1016\/j.whi.2005.12.001_bib14","first-page":"5","article-title":"Labeling changes for mifepristone","volume":"39","year":"2005","journal-title":"FDA Consumer"},{"key":"10.1016\/j.whi.2005.12.001_bib15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1363\/3500603","article-title":"Abortion incidence and services in the United States in 2000","volume":"35","author":"Finer","year":"2003","journal-title":"Perspectives on Sexual and Reproductive Health"},{"key":"10.1016\/j.whi.2005.12.001_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.publhealth.26.021304.144610","article-title":"Social marketing in public health","volume":"26","author":"Grier","year":"2005","journal-title":"Annual Review of Public Health"},{"issue":"2 Suppl","key":"10.1016\/j.whi.2005.12.001_bib17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mob.2000.106047","article-title":"Medical abortion","volume":"183","author":"Grimes","year":"2000","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.whi.2005.12.001_bib18","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-140-8-200404200-00009","article-title":"Induced abortion","volume":"140","author":"Grimes","year":"2004","journal-title":"Annals of Internal Medicine"},{"issue":"3 Suppl","key":"10.1016\/j.whi.2005.12.001_bib19","first-page":"161","article-title":"Experiences and satisfaction with providing methotrexate-induced abortions among U.S. providers","volume":"55","author":"Harvey","year":"2000","journal-title":"Journal of the American Medical Women\u2019s Association"},{"key":"10.1016\/j.whi.2005.12.001_bib20","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2307\/2673784","article-title":"Choice of and satisfaction with methods of medical and surgical abortion among U.S. Clinic patients","volume":"33","author":"Harvey","year":"2001","journal-title":"Family Planning Perspectives"},{"key":"10.1016\/j.whi.2005.12.001_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0010-7824(03)00049-0","article-title":"Mifepristone and misoprostol for early medical abortion","volume":"67","author":"Hausknecht","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.whi.2005.12.001_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1363\/3501603","article-title":"The accessibility of abortion services in the U.S.","volume":"35","author":"Henshaw","year":"2003","journal-title":"Perspectives on Sexual and Reproductive Health"},{"key":"10.1016\/j.whi.2005.12.001_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2307\/2991555","article-title":"Reactions to medical abortion among providers of surgical abortion","volume":"31","author":"Joffe","year":"1999","journal-title":"Family Planning Perspectives"},{"issue":"Suppl 2","key":"10.1016\/j.whi.2005.12.001_bib25","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1067\/mob.2000.108232","article-title":"Medical abortion in social context","volume":"183","author":"Joffe","year":"2000","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.whi.2005.12.001_bib26","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/S0277-9536(02)00240-X","article-title":"Normalizing the exceptional","volume":"56","author":"Joffe","year":"2003","journal-title":"Social Sciences & Medicine"},{"key":"10.1016\/j.whi.2005.12.001_bib27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2307\/3097714","article-title":"Mifepristone for early medical abortion","volume":"34","author":"Jones","year":"2002","journal-title":"Perspectives on Sexual and Reproductive Health"},{"key":"10.1016\/j.whi.2005.12.001_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(99)00115-8","article-title":"The efficacy of medical abortion","volume":"61","author":"Kahn","year":"2000","journal-title":"Contraception"},{"issue":"Suppl 3","key":"10.1016\/j.whi.2005.12.001_bib29","first-page":"155","article-title":"Are U.S. health professionals likely to prescribe mifepristone or methotrexate?","volume":"55","author":"Koenig","year":"2000","journal-title":"Journal of the American Medical Women\u2019s Association"},{"key":"10.1016\/j.whi.2005.12.001_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002855.pub3","article-title":"Medical methods for first trimester abortion","author":"Kulier","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.whi.2005.12.001_bib31","first-page":"655","article-title":"Racial\/ethnic disparities in neonatal mortality\u2014United States, 1989\u20132001","volume":"53","author":"Lukacs","year":"2004","journal-title":"Surveillance Summaries"},{"key":"10.1016\/j.whi.2005.12.001_bib32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1517\/14656566.4.4.503","article-title":"Pharmacoeconomics of medical abortion","volume":"4","author":"Murthy","year":"2003","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"2 Suppl","key":"10.1016\/j.whi.2005.12.001_bib33","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1067\/mob.2000.107950","article-title":"Abortion with mifepristone and misoprostol","volume":"183","author":"Newhall","year":"2000","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1016\/j.whi.2005.12.001_bib34","first-page":"1","article-title":"Surveillance for disparities in maternal health-related behaviors\u2014Selected states, pregnancy risk assessment monitoring system (prams), 2000\u20132001","volume":"53","author":"Phares","year":"2004","journal-title":"Surveillance Summaries"},{"key":"10.1016\/j.whi.2005.12.001_bib35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3122\/jabfm.16.4.290","article-title":"Medical abortion in family practice","volume":"16","author":"Prine","year":"2003","journal-title":"Journal of the American Board of Family Practice"},{"key":"10.1016\/j.whi.2005.12.001_bib36","series-title":"Health behavior and health education","first-page":"99","article-title":"The transtheoretical model and stages of change","author":"Prochaska","year":"2002"},{"key":"10.1016\/j.whi.2005.12.001_bib37","series-title":"Diffusion of innovation","author":"Rogers","year":"1983"},{"key":"10.1016\/j.whi.2005.12.001_bib38","doi-asserted-by":"crossref","first-page":"I129","DOI":"10.1097\/00005650-200006001-00013","article-title":"From understanding health care provider to improving health care","volume":"38","author":"Rubenstein","year":"2000","journal-title":"Medical Care"},{"key":"10.1016\/j.whi.2005.12.001_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(98)00150-4","article-title":"Low-dose mifepristone 200 mg and vaginal misoprostol for abortion","volume":"59","author":"Schaff","year":"1999","journal-title":"Contraception"},{"issue":"Suppl 3","key":"10.1016\/j.whi.2005.12.001_bib40","first-page":"137","article-title":"A comparison of the abortion rights mobilization and population council trials","volume":"55","author":"Schaff","year":"2000","journal-title":"Journal of the American Medical Women\u2019s Association"},{"key":"10.1016\/j.whi.2005.12.001_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0010-7824(01)00229-3","article-title":"Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion","volume":"64","author":"Schaff","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.whi.2005.12.001_bib42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0010-7824(02)00366-9","article-title":"Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy","volume":"66","author":"Schaff","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.whi.2005.12.001_bib43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.whi.2004.08.011","article-title":"Willing and able? Provision of medication for abortion by future internists","volume":"15","author":"Schwarz","year":"2005","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.whi.2005.12.001_bib44","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0277-9536(97)10063-6","article-title":"Abortion, revised","volume":"46","author":"Simonds","year":"1998","journal-title":"Social Science & Medicine"},{"key":"10.1016\/j.whi.2005.12.001_bib45","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM199804303381801","article-title":"Early pregnancy termination with mifepristone and misoprostol in the United States","volume":"338","author":"Spitz","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"6903","key":"10.1016\/j.whi.2005.12.001_bib46","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/bmj.307.6903.532","article-title":"Termination of pregnancy with reduced doses of mifepristone","volume":"307","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.whi.2005.12.001_bib47","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1471-0528.2000.tb13273.x","article-title":"Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion","volume":"107","year":"2000","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.whi.2005.12.001_bib48","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMe058148","article-title":"Pregnancy failure and misoprostol\u2014time for a change","volume":"353","author":"Winikoff","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.whi.2005.12.001_bib49","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/archfami.7.4.360","article-title":"Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol. Results of a large multicenter trial in the United States. Mifepristone clinical trials group","volume":"7","author":"Winikoff","year":"1998","journal-title":"Archives of Family Medicine"}],"container-title":["Women's Health Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104938670500109X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104938670500109X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T12:29:10Z","timestamp":1547814550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104938670500109X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S104938670500109X"],"URL":"https:\/\/doi.org\/10.1016\/j.whi.2005.12.001","relation":{},"ISSN":["1049-3867"],"issn-type":[{"value":"1049-3867","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}